申请人:Neurocrine Biosciences, Inc
公开号:US20020151557A1
公开(公告)日:2002-10-17
CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.
本发明揭示了CRF受体拮抗剂,其在治疗各种疾病方面具有用途,包括治疗温血动物中CRF分泌过多的疾病,如中风。